Since CBN, CBG and Delta 8 Are Not Improved And FDA Approved Drug Will They Face The Same Marketing And Banking Issues As A CBD Product? – Rod Kight

Rod Kight is a licensed attorney in North Carolina and Oregon who represents businesses in the cannabis industry in the US and internationally. He consults and assist with strategic planning, advises on compliance issues, and offer a full array of business services to the cannabis sector, including hemp, CBD and other cannabinoids, medical marijuana, and adult-use marijuana

In this video, Rod Kight explains that CBN, CBG and Delta 8 are not improved and FDA-approved drugs. Will they face the same marketing and banking issues as a CBD product?

All full interviews are available for CBD Business Accelerator members.

Use code ’10DOLLAR’ to get your first month for only $10. Click Here

The CBD Business Accelerator includes direct access to over 50 vetted experts who are brand owners, marketers, advertisers, industry titans and more. We are a community built to support each other while sharing high value information and ideas with each other. Included with the membership is access to our buy/sell network, our massive digital library of content, exclusive access to our private Facebook group & more! Learn more here: CLICK HERE to learn more.